Skip to main content
INVENTISBIO CO., LIMITED. logo

INVENTISBIO CO., LIMITED. — Investor Relations & Filings

Ticker · 688382 ISIN · CNE100005Q22 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 446 across all filing types
Latest filing 2023-12-08 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688382

About INVENTISBIO CO., LIMITED.

https://www.inventisbio.com/

InventisBio Co., Ltd. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative small molecule therapeutics. The company focuses on addressing unmet medical needs in oncology and metabolic diseases. Its research and development pipeline includes several high-potential candidates, such as befotertinib, a third-generation EGFR tyrosine kinase inhibitor for non-small cell lung cancer, and garsorasib, a potent KRAS G12C inhibitor. Additionally, the company is developing D-0502, an oral selective estrogen receptor degrader for breast cancer, and D-0120, a selective URAT1 inhibitor for the treatment of hyperuricemia and gout. InventisBio leverages its proprietary drug discovery platform and global clinical development expertise to advance a diverse portfolio of targeted therapies aimed at improving patient outcomes through precision medicine.

Recent filings

Filing Released Lang Actions
益方生物第二届监事会2023年第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution from the company's Supervisory Board meeting, specifically about the election of the Supervisory Board Chairman. It details the meeting attendance, voting results, and the appointment of a new chairman. There is no financial data, no mention of annual or quarterly reports, no audit information, and no regulatory filings or certifications. This fits the category of Board/Management Information (MANG), as it concerns changes in the company's board or senior management structure.
2023-12-08 Chinese
君合律师事务所上海分所关于益方生物科技（上海）股份有限公司2023年第三次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the convening, procedures, and results of a company's 2023 third extraordinary general meeting (临时股东大会). It details the legality of the meeting's call, attendance, voting procedures, and results, including election of board members and amendments to company governance documents. The document does not contain financial statements or management discussion of financial results, nor is it a transcript or presentation. It is a legal opinion related to a shareholders' meeting and the voting outcomes. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results and validates the meeting procedures and outcomes. The document length is sufficient and contains detailed voting results, not just an announcement of a report. Therefore, the classification is DVA with high confidence.
2023-12-08 Chinese
益方生物独立董事关于第二届董事会2023年第一次会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on the resolutions of the company's second board meeting in 2023. It discusses the appointment of senior management positions such as general manager, deputy general managers, financial director, and board secretary. The content focuses on board/management changes and approvals rather than financial results, audit, or regulatory filings. The document length is short (1591 characters) and contains detailed opinions on management appointments, which fits the category of Board/Management Information (MANG).
2023-12-08 Chinese
益方生物2023年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the company's 2023 third extraordinary general meeting of shareholders, including voting results for various proposals such as amendments to the company charter, election of board members, and other governance matters. It includes attendance details, voting percentages, and lawyer's witness statements confirming the legality of the meeting and voting process. There is no financial data or report content, but rather the official results of shareholder votes at a general meeting. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is 4147 characters, which is sufficient for a full voting results announcement rather than a brief notice. Therefore, the correct classification is DVA with high confidence.
2023-12-08 Chinese
益方生物关于选举职工代表监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of employee representative supervisors to the company's supervisory board. It includes details about the election process, the individuals elected, their qualifications, and compliance with relevant laws and regulations. There is no financial data, no mention of financial results, no discussion of management changes at the executive or board director level, and no reference to any report publication or regulatory filing. The content is focused on governance-related personnel election but specifically about supervisory board members (employee representatives), which is a form of board/management information. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is short and it is not a report or a report announcement, so it does not fit other categories.
2023-12-08 Chinese
益方生物2023年第三次临时股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as materials for the 2023 third extraordinary shareholders meeting of Yifang Bio-Technology (Shanghai) Co., Ltd. It includes meeting notices, agenda, and detailed proposals for amendments to company bylaws, governance rules, and board and supervisory committee elections. The content is focused on the organization and conduct of a shareholders meeting, including voting procedures and legal compliance. There is no financial data, earnings information, or audit content. The document is clearly a set of meeting materials for a shareholders meeting, not the meeting minutes or voting results. Therefore, it fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or other shareholders meetings.
2023-12-01 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.